Back

Dapagliflozin attenuates post-infarction inflammation and remodeling via promoting metabolic reprogramming–driven cardiac lymphangiogenesis

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: From infarction to recovery: SGLT2 and rehabilitation in heart failure Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Zhu Zhang

(China)

6 More presentations in this session

Presentation thumbnail
Heart failure therapy optimization in myocardial infarction patients with systolic dysfunction during Phase 2 and 3 Cardiac Rehabilitation
Doctor S. Cardona Tercero (Valencia, ES)
Abstract
Presentation thumbnail
Does symptom profile modify revascularization benefit in ischemic LV dysfunction? A win ratio analysis pooling STICHES and REVIVED-BCIS2
Doctor G. Tong (New Haven, US)
Abstract
Presentation thumbnail
Effects of beta-blocker treatment on circulating biomarkers of fibrosis in patients with myocardial infarction without heart failure: A substudy of the BETAMI-DANBLOCK trial
Professor I. Lunde (Oslo, NO)
Abstract
Presentation thumbnail
Differences in survival outcomes and LVEF of self-expanding versus balloon expandable valves after TAVI in patients with severe cardiac dysfunction
Doctor A. Matta (Toulouse, FR)
Abstract
Presentation thumbnail
Reversal of residual left ventricular remodeling in corrected primary valvular regurgitation: is it different from dilated cardiomyopathy
Mr R. Zhang (Chengdu, CN)
Abstract

Access the full session

Session thumbnail
From infarction to recovery: SGLT2 and rehabilitation in heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk
31 August 2025
thumbnail
Congress Presentation
Combined transcriptomics, proteomics and metabolomics analysis identifies metabolic pathways associated with the loss of cardiac regeneration
20 April 2018
thumbnail
Congress Presentation
Rarefaction of myocardial lymphatic vessels in patients with cardiac amyloidosis
22 May 2023
thumbnail
Congress Presentation
DAMPs exacerbate post-myocardial infarction cardiac injury via suppression of AP-1 signaling: critical role of impaired lymphatic endothelial cell proliferation
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources